Akari Therapeutics Plc (AKTX)

0.3936 0.00 (0.00%) USD  |  NASDAQ  |  Dec 15, 16:00
0.3936 0.00 (0.00%) After-Hours: 18:13
More

Akari Therapeutics Gross Profit (Quarterly): 0.00 for Sept. 30, 2025

Gross Profit (Quarterly) Chart

View Gross Profit (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross Profit Definition

View Gross Profit Definition
Start Trial

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Quarterly) Range, Past 5 Years

View Gross Profit (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Quarterly) Benchmarks

View Gross Profit (Quarterly) Benchmarks
Start Trial
DBV Technologies SA -4.282M
Cellectis SA 30.03M
Biodexa Pharmaceuticals Plc --
NuCana Plc -0.093M
Autolus Therapeutics Plc -10.79M